Taking Mounjaro and Citalopram Together: What the Evidence Says

The gastric-emptying effect: why it matters for oral medicines

Tirzepatide is a dual GIP and GLP-1 receptor agonist. One of its mechanisms is slowing the rate at which food and liquid leave the stomach. This is useful for appetite regulation, but it also means that oral tablets taken at the same time may sit in the stomach longer before being absorbed. For some medicines (those with a narrow therapeutic window or time-sensitive peaks) this can be clinically significant.

Citalopram is an SSRI with a relatively predictable absorption profile. It does not have the narrow therapeutic window of, say, warfarin or digoxin, which makes the gastric-emptying effect less acutely dangerous. However, any consistent shift in how quickly citalopram reaches peak plasma concentration could theoretically affect symptom control, particularly during the early weeks of Mounjaro treatment when the gastric-slowing effect is most pronounced. The Mounjaro SmPC on the electronic Medicines Compendium advises that medicines dependent on threshold concentrations for effect should be monitored when starting tirzepatide. That is a conversation worth having with your GP or prescriber proactively.

In practice, most people on stable antidepressant therapy do not report their medication stopping working when they add tirzepatide, but the clinical principle stands: tell every clinician involved in your care what you take.

Can you take Mounjaro with citalopram? Framing the real decision

The honest answer is that tirzepatide and citalopram are not contraindicated. There is no evidence that combining them causes a dangerous reaction. What exists is a theoretical mechanism (altered oral drug absorption) that warrants awareness rather than alarm. The prescriber's job is to factor your full medication list into the suitability assessment, and citalopram would be noted as part of that picture.

If you are well-established on citalopram, feel your mental health is stable, and are considering Mounjaro for weight management, the relevant questions your prescriber will explore include: are you on a dose of citalopram where a small shift in absorption would matter clinically, and do you have a GP or mental health team who can monitor you through the early titration period? These are practical, answerable questions. They are not a reason to assume Mounjaro is off-limits. Understanding your full tirzepatide clinical profile helps you go into that conversation prepared.

It's worth acknowledging that if you are taking citalopram, starting a new treatment (one that also affects your appetite, mood around eating, and physical wellbeing) can feel like a lot to manage at once. That concern is legitimate and a good prescriber will take it seriously.

Overlapping side effects: what to watch for

Both medicines can produce gastrointestinal symptoms. Mounjaro's most common effects are nausea, loose stools, constipation, indigestion and reduced appetite, especially in the first weeks at a new dose. Citalopram can also cause nausea, dry mouth and, in some people, appetite changes. Starting Mounjaro does not automatically make citalopram side effects worse, but distinguishing which medicine is responsible for a given symptom can take a little attention. Our guide to nausea on Mounjaro covers the practical steps that help most people through that adjustment period.

There is also the question of mood during weight-loss treatment. Some people on GLP-1 medicines report shifts in mood or energy, particularly early on when calorie intake drops and the body is adapting. If you are on citalopram for depression or anxiety, it is worth flagging to your GP that you are starting Mounjaro, so they can keep an eye on your mental health during the first few months, not because a problem is expected, but because good clinical oversight is how small issues stay small.

The NHS patient information on tirzepatide lists what to report and when to seek urgent help. For side-effect monitoring that extends to your mental health, your GP is the right first contact. Other medicines can present similar monitoring questions; our pages on Mounjaro and propranolol and Mounjaro and pantoprazole walk through comparable scenarios, and if you are curious about how anti-nausea medication fits into this picture, our page on metoclopramide and Mounjaro explains how that combination is approached.

What to do before starting Mounjaro if you take citalopram

Preparation here is straightforward. Tell your prescriber (at nume or elsewhere) that you take citalopram, including the dose and how long you have been on it. Mention whether your mental health is currently stable or if you have had a recent change. If you have a regular GP, a brief message or appointment to let them know you are starting a new weight-loss injection is sensible clinical housekeeping. The NHS England guidance on weight management injections recommends that GPs are kept informed of patients taking these medicines, and at nume GP notification is part of how we practise.

If you'd like to understand what else a consultation covers (including how other medicines interact with Mounjaro) our Mounjaro overview is a useful starting point, and our FAQs cover many of the questions people ask before their first consultation. You can also look at the treatment options available through nume if you want to compare before deciding.

When you are ready to take the next step, you can speak to our prescribers through a free consultation at our weight-loss treatments page. There are no hidden fees and no subscription attached to that conversation.